ArticleNature2019
Publisher Correction: Group 3 innate lymphoid cells mediate early protective immunity against tuberculosis.
Abstract readPublished Erratum
In one paragraph
Article in Nature, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum for
Authors and funding
36 authors.
Amanda Ardain *Africa Health Research Institute, Durban, South Africa.
Racquel Domingo-Gonzalez *Department of Molecular Microbiology, Washington University School of Medicine, St Louis, MO, USA.
Shibali Das *Department of Molecular Microbiology, Washington University School of Medicine, St Louis, MO, USA.
Samuel W KazerInstitute for Medical Engineering and Science, Department of Chemistry, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
Nicole C HowardDepartment of Molecular Microbiology, Washington University School of Medicine, St Louis, MO, USA.
Alveera SinghAfrica Health Research Institute, Durban, South Africa.
Mushtaq AhmedDepartment of Molecular Microbiology, Washington University School of Medicine, St Louis, MO, USA.
Shepherd NhamoyebondeAfrica Health Research Institute, Durban, South Africa.
Javier Rangel-MorenoDivision of Allergy, Immmunology and Rheumatology, Department of Medicine, Universtiy of Rochester Medical Center, Rochester, NY, USA.
Paul OgongoAfrica Health Research Institute, Durban, South Africa.
Lan LuDepartment of Molecular Microbiology, Washington University School of Medicine, St Louis, MO, USA.
Duran RamsuranSchool of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.
Maria de la Luz Garcia-HernandezDivision of Allergy, Immmunology and Rheumatology, Department of Medicine, Universtiy of Rochester Medical Center, Rochester, NY, USA.
Tyler K UllandDivision of Immunobiology, Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Matthew DarbyIDM, University of Cape Town, Cape Town, South Africa.
Eugene ParkDivision of Immunobiology, Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Farina KarimAfrica Health Research Institute, Durban, South Africa.
Laura MelocchiDivision of Immunobiology, Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Rajhmun MadanseinDepartment of Cardiothoracic Surgery, Nelson Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
Kaylesh Jay DullabhDepartment of Cardiothoracic Surgery, Nelson Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
Micah DunlapDepartment of Molecular Microbiology, Washington University School of Medicine, St Louis, MO, USA.
Nancy Marin-AgudeloDepartment of Molecular Microbiology, Washington University School of Medicine, St Louis, MO, USA.
Takashi EbiharaDivision of Immunobiology, Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Thumbi Ndung'uAfrica Health Research Institute, Durban, South Africa.
Deepak KaushalTulane National Primate Research Center, Covington, LA, USA.
Alexander S PymAfrica Health Research Institute, Durban, South Africa.
Jay K KollsTulane University Health Sciences, New Orleans, LA, USA.
Adrie SteynAfrica Health Research Institute, Durban, South Africa.
Joaquín ZúñigaInstituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, Mexico City, Mexico.
William HorsnellIDM, University of Cape Town, Cape Town, South Africa.
Wayne M YokoyamaDivision of Immunobiology, Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Alex K ShalekInstitute for Medical Engineering and Science, Department of Chemistry, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
Henrik N KløverprisAfrica Health Research Institute, Durban, South Africa.
Marco ColonnaDivision of Immunobiology, Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Alasdair LeslieAfrica Health Research Institute, Durban, South Africa. al.leslie@ahri.org.
Shabaana A KhaderDepartment of Molecular Microbiology, Washington University School of Medicine, St Louis, MO, USA. sakhader@wustl.edu.
Funding
ROLE OF INDUCIBLE BRONCHUS ASSOCIATED LYMPHOID TISSUE IN LATENT TUBERCULOSISR01AI111914 · NIAID · WASHINGTON UNIVERSITY · PI KAUSHAL, DEEPAK, KHADER, SHABAANA A. · 2015 to 2025
$11.1MROLE OF IL-17 IN PROTECTIVE VACCINE-INDUCED IMMUNE RESPONSES AGAINST TUBERCULOSISR01HL105427 · NHLBI · WASHINGTON UNIVERSITY · PI KHADER, SHABAANA A. · 2011 to 2025
$5.9MThe Role of Group 3 Innate Lymphoid cells (ILC3) in TuberculosisR01AI134236 · NIAID · WASHINGTON UNIVERSITY · PI COLONNA, MARCO, KHADER, SHABAANA A. · 2017 to 2021
$4.4MCOMMON IMMUNE CORRELATES OF RISK OF TB DISEASE IN ANIMAL MODELS AND HUMANSR01AI123780 · NIAID · WASHINGTON UNIVERSITY · PI KAUSHAL, DEEPAK, KHADER, SHABAANA A. · 2016 to 2019
$2.9MAn integrated multiplexed genomic assay for low input clinical samples1U24AI118672 · NIAID · BROAD INSTITUTE, INC. · PI SHALEK, ALEX K · 2015 to 2019
$2.0MNHLBI NIH HHS R01 HL105427NIAID NIH HHS R01 AI111914NIAID NIH HHS R01 AI123780NIAID NIH HHS R01 AI134236NIAID NIH HHS U24 AI118672
Abstract
An Amendment to this paper has been published and can be accessed via a link at the top of the paper.
Identifiers
PMID
31337923What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.